SZIVIZOM INFARCTUST ELSZENVEDETT BETEGEK GYOGYSZERES ES NEM-GYOGYSZERES KEZELESE (AZ INFARCTUS MASODLAGOS MEGELOZESE)

Translated title of the contribution: Pharmacological and non-pharmacological treatment of patients with chronic myocardial infarction (Secondary prevention of myocardial infarction)

Research output: Contribution to journalReview article

Abstract

Risk factors predisposing to ischaemic heart disease can be divided into non-correctable (familiar aggregation of the disease, age and factors. The latter are as follows: hyperlipidaemia, smoking, hypertension, diabetes mellitus, sedentary lifestyle, elevated plasma fibrinogen level and decreased oestrogen level at females. The secondary prevention of myocardial infarction should consist of the screening of correctable risk factors, and drug treatment being still proved to be effective in large population studies (beta adrenoreceptor blockers, angiotensin converting enzyme inhibitors, platelet inhibitors and in certain cases nitrates and calcium antagonists). In a subset of patients surgical corrections (coronary artery bypass grafting) and physical/mental rehabilitation for all of the patients are also needed.

Translated title of the contributionPharmacological and non-pharmacological treatment of patients with chronic myocardial infarction (Secondary prevention of myocardial infarction)
Original languageHungarian
Pages (from-to)3-10
Number of pages8
JournalOrvoskepzes
Volume71
Issue number1
Publication statusPublished - Jan 1 1996

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Pharmacological and non-pharmacological treatment of patients with chronic myocardial infarction (Secondary prevention of myocardial infarction)'. Together they form a unique fingerprint.

  • Cite this